Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Denosumab may cause alopecia areata.

Methotrexate plus prednisolone had the fewest serious side effects.

Upadacitinib effectively treats severe alopecia areata and is safe.

Monoclonal antibodies are often linked to alopecia areata cases.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

The treatment combination is safe and effective for some patients with this type of breast cancer.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

The adapalene-benzoyl peroxide gel works better and faster for acne treatment than using either ingredient alone, with manageable side effects.

Abrocitinib may effectively treat stubborn alopecia universalis.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.